The potential rematch between newly minted UFC Interim Welterweight champion Carlos Condit and Nick Diaz is on hold for the time being. This is due to the fact that the former Strikeforce Welterweight champion Diaz has again failed another post fight drug test.
Earlier this afternoon Nevada State Athletic Commissioner(NSAC) Keith Kizer alerted media that at least one UFC 143 competitor had failed the test. The positive test was for drugs of abuse or performance-enhancing drugs. Kizer later on in the day confirmed Diaz was in fact the person with the failed test.
Diaz for the second time, failed the test in Las Vegas due to marijuana use. His first failed test came back at Pride 33 when he fought Takanori Gomi 02.24.2007. Diaz initially won that fight by submission (gogoplata). That victory was overturned and later ruled a no contest because of the failed test.
This failed test should quiet all the Diaz fans that were clamoring for a rematch with Condit. Condit put on a masterful, technical fight at UFC 143 to claim the UFC's interim welterweight title. What is next for the Stockton Bad Boy Diaz? Most likely a year suspension and fine. With the extended time off will he in fact retire from Mixed Martial Arts or have his passion renewed for the sport that has made him famous and rich? One thing is for certain, a Georges St Pierre vs Condit UFC welterweight title unification bout is next. Most likely in November at the Bell Centre in Montreal, Canada
Need a boost of energy to get thru the day? Try Advocare's Spark Energy Drink. Mix powder with water and your good too go!
OVERVIEW
- Available in Mango Strawberry, Pink Lemonade, Mandarin Orange, Fruit Punch, Grape, Citrus and Cherry
- Offered in pouches and canisters
- Our #1 seller
- The most nutritionally advanced energy drink on the market
- Sugar-free, long-lasting energy*
- Surprisingly fast-acting*
- Contains 21 vitamins, minerals and nutrients designed to synergistically provide a healthy, balanced source of energy*
- Just 45 calories per serving
- Sharpens mental focus*
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.